Skip to main content
. 2009 Dec 11;115(6):1131–1136. doi: 10.1182/blood-2009-10-246363

Figure 1.

Figure 1

MF patients who responded to CEP-701. (A) Spleen size measurements in MF patients who responded to CEP-701. Data are shown for 4 patients who had a decrease in spleen size on therapy. (B) JAK2V617F allele burden in MF patients who responded to CEP-701. Data are shown for all 6 clinical responders.